â??A randomized, double blind, placebo controlled, cross over study to evaluate the analgesic activity of Terminalia chebula in healthy human participants using thermal pain modelsâ??.

IZAMS INSTITUTE OF MEDICAL SCIENCES0 个研究点目标入组 24 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Healthy male participants aged 18 â?? 45yr, with a body mass index (BMI) 19.5 â?? 25.9 kg/m2 will be included in the study.
•The participants having pain tolerance time between 30 sec and 180 sec with short level and high heat intensity will be included into the study.
•Patients who will provide written informed consent to participate in the study.
•Able to perform the test, as per protocol procedure
•No history of diabetes ,hypertension, GIT disorders

•Uncooperative subjects.
•Prior wounds or fractures on the tested extremity
•Any significant abnormality identified on physical examination or laboratory tests.
•Smokers, Alcoholics, drug abusers (amphetamines, cocaine, sympathomimetics, systemic glucocorticoids, anabolic steroids, will be not included in the study.
•Participants using other anti oxidants and over the counter medications.
•Participants using other non-steroidal anti-inflammatory drugs in the past 2 weeks.
•Use of other investigational drugs at the time of enrollment, or within 3 months prior to this study.
•History of hypersensitivity to the study drug

发起方

IZAMS INSTITUTE OF MEDICAL SCIENCES